From: genomeweb.com August 8, 2019 – The Centers for Medicare & Medicaid Services announced yesterday that it would be covering approved CAR-T therapies for Medicare patients, the Associated Press reports. The US Food and Drug Administration approved Novartis’ CAR-T therapy Kymriah about two years ago to treat a form of acute lymphoblastic leukemia and shortly thereafter approved Kite Pharmaceuticals’ Yescarta, …
Knight Therapeutics Announces Health Canada Has Approved NERLYNX ® for Early-Stage Breast Cancer
From: globenewswire.com Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, announced today that Health Canada has approved NERLYNX® (neratinib) for the extended adjuvant treatment of women with early-stage hormone receptor positive, HER2-overexpressed/amplified breast cancer within one year after completion of trastuzumab-based adjuvant therapy1. Knight has the exclusive right to commercialize NERLYNX® in Canada under a license agreement …
Every data point has a face: What Michael Becker taught us
By: Matthew Herper From: statnews.com Michael Becker was a biotech executive before he was a patient advocate. When he discovered he had head and neck cancer, he decided to go public, and in doing so made an impact — both within the drug industry and beyond. Cancer, Becker once said, takes away a lot more than it gives. But he …
As a young mother dies after refusing chemotherapy, how social media is fuelling the rise of fake cancer cures
By: Margarette Driscoll From: telegraph.co.uk Last week, at a converted 18th-century farmhouse near Derby, friends gathered in memory of Katie Britton-Jordan, who died recently after a valiant struggle against breast cancer. She was 38 and leaves a grieving husband, Neil, and Delilah, their five-year-old daughter. Neil, who announced his wife’s death on Facebook earlier this month, called for the event …
HealthTree® Patient Portal Surpasses 4,200 Users Representing 4% of All Multiple Myeloma Patients in the U.S.
Online Patient Platform Providing Treatment Options and a Path to a Cure HealthTree®, the first and only online portal for multiple myeloma cancer patients to find their best treatment options and help accelerate a cure, today announced it has reached more than 4,200 patient users on its unique platform. Designed primarily to help patients to navigate their disease in a …
Remembering to take your medication isn’t just an old people problem
By: Brad Gantt Source: Tooktake Woman & Mom owned business Tooktake announces the release of their Patent Pending product to help people get well and stay well, one dose at a time. Tooktake dosage reminder labels were born out of the founder, Leeanna Gantt’s own challenges and experiences while in treatment for breast cancer. She was given a cabinet-full of …
Metastases May Form Early in Development of Colorectal Cancer
By: Staff Reporter From: genomeweb.com Many colorectal cancer metastases may have arisen and spread even before the primary tumor was large enough to be detected, according to a new study. A Stanford University-led team of researchers used exome sequencing data from patients with metastatic colorectal cancer to examine how the cancer spread to distant sites. Generally, metastases have been thought …
Study Confirms Disparities in Triple-Negative Breast Cancer Diagnoses
Source: Wiley Research News From: prnewswire.com A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elevated risks of developing triple-negative breast cancers, which are often aggressive and do not respond to hormone therapy or targeted therapy. Previous U.S. studies have found racial disparities in triple-negative …
Heart disease is lasting threat to breast cancer survivors
Source: HealthDay From: upi.com Postmenopausal women who survive breast cancer may have a higher risk for developing heart disease, a new study says. Heart problems can appear more than five years after radiation treatment for breast cancer, and the added risk persists for as much as 30 years, according to Brazilian researchers. Heart disease is the leading cause of death …
Maria Lewis
Two years ago in the summer of 2017, Maria Lewis from Salt Lake City was told by her oncologist at a large local cancer institute that she had Triple Negative breast cancer. She was given three to six months to live with little hope of any treatment working. The cancer institute offered a counselor to discuss getting her affairs in order. But Maria …